Clinical Trial Update: Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy [Phase 4]

View source ↗

Summary

Update on a Phase 4 trial evaluating intravitreal aflibercept (Eylea) for persistent macular edema due to central retinal vein occlusion in patients with prior …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Tennessee Retina | Conditions: Retinal Vein Occlusion | Phase 4 | Status: UNKNOWN